dorzolamide/timolol apotex 20/5 dorzolamide/timolol eye drops
arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg); dorzolamide hydrochloride, quantity: 22.3 mg/ml (equivalent: dorzolamide, qty 20 mg) - eye drops, solution - excipient ingredients: mannitol; sodium citrate dihydrate; water for injections; benzalkonium chloride; sodium hydroxide; hyetellose - dorzolamide/timolol 20/5 eye drops are indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
dorzolamide-timolol pf solution
micro labs limited - timolol (timolol maleate); dorzolamide (dorzolamide hydrochloride) - solution - 5mg; 20mg - timolol (timolol maleate) 5mg; dorzolamide (dorzolamide hydrochloride) 20mg
dorzolamide-timolol solution
micro labs limited - timolol (timolol maleate); dorzolamide (dorzolamide hydrochloride) - solution - 5mg; 20mg - timolol (timolol maleate) 5mg; dorzolamide (dorzolamide hydrochloride) 20mg
dorzolamide-timolol solution
alcon canada inc - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 2.0%; 0.5% - dorzolamide (dorzolamide hydrochloride) 2.0%; timolol (timolol maleate) 0.5% - beta-adrenergic agents
apo-dorzolamide/timolol 20/5 dorzolamide/timolol eye drops
apotex pty ltd - dorzolamide hydrochloride,timolol maleate -
dorzolamide-timolol solution
jamp pharma corporation - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 20mg; 5mg - dorzolamide (dorzolamide hydrochloride) 20mg; timolol (timolol maleate) 5mg - beta-adrenergic agents
timolol mlabs 0.25% timolol (as maleate) 2.5 mg/ ml eye drops solution bottle
micro labs pty ltd - timolol maleate, quantity: 3.4 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; dibasic sodium phosphate dodecahydrate; benzalkonium chloride; water for injections; monobasic sodium phosphate dihydrate - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma.
timolol mlabs 0.5% timolol (as maleate) 5 mg/ml eye drops solution bottle
micro labs pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: water for injections; monobasic sodium phosphate dihydrate; sodium hydroxide; dibasic sodium phosphate dodecahydrate; benzalkonium chloride - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma
timolol b&b 0.25% timolol (as maleate) 2.5 mg/ml eye drops solution bottle
micro labs pty ltd - timolol maleate, quantity: 3.4 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: water for injections; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; benzalkonium chloride - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma.
timolol mlpl 0.25% timolol (as maleate) 2.5 mg/ml eye drops solution bottle
micro labs pty ltd - timolol maleate, quantity: 3.4 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; sodium hydroxide; water for injections - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma.